These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 18505927)
1. The biphasic role of the hypoxia-inducible factor prolyl-4-hydroxylase, PHD2, in modulating tumor-forming potential. Lee K A; Lynd JD; O'Reilly S; Kiupel M; McCormick JJ; LaPres JJ Mol Cancer Res; 2008 May; 6(5):829-42. PubMed ID: 18505927 [TBL] [Abstract][Full Text] [Related]
2. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness. Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060 [TBL] [Abstract][Full Text] [Related]
3. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors. Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863 [TBL] [Abstract][Full Text] [Related]
4. Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer. Su Y; Loos M; Giese N; Metzen E; Büchler MW; Friess H; Kornberg A; Büchler P Cancer; 2012 Feb; 118(4):960-72. PubMed ID: 21792862 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer. Li Y; Zhang D; Wang X; Yao X; Ye C; Zhang S; Wang H; Chang C; Xia H; Wang YC; Fang J; Yan J; Ying H Sci Rep; 2015 Jul; 5():12495. PubMed ID: 26205124 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of hypoxia-inducible factor prolyl hydoxylase-2 attenuates hypoxia-induced vascular endothelial growth factor expression in luteal cells. Zhang Z; Pang X; Tang Z; Yin D; Wang Z Mol Med Rep; 2015 Sep; 12(3):3809-3814. PubMed ID: 25975603 [TBL] [Abstract][Full Text] [Related]
13. PHD2 in tumour angiogenesis. Chan DA; Giaccia AJ Br J Cancer; 2010 Jun; 103(1):1-5. PubMed ID: 20461086 [TBL] [Abstract][Full Text] [Related]
14. HIF-prolyl hydroxylases and cardiovascular diseases. Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133 [TBL] [Abstract][Full Text] [Related]
15. Expression of the cellular oxygen sensor PHD2 (EGLN-1) predicts radiation sensitivity in squamous cell cancer of the head and neck. Luukkaa M; Jokilehto T; Kronqvist P; Vahlberg T; Grénman R; Jaakkola P; Minn H Int J Radiat Biol; 2009; 85(10):900-8. PubMed ID: 19639506 [TBL] [Abstract][Full Text] [Related]
16. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha. Dayan F; Roux D; Brahimi-Horn MC; Pouyssegur J; Mazure NM Cancer Res; 2006 Apr; 66(7):3688-98. PubMed ID: 16585195 [TBL] [Abstract][Full Text] [Related]
17. Short hairpin RNA interference therapy for ischemic heart disease. Huang M; Chan DA; Jia F; Xie X; Li Z; Hoyt G; Robbins RC; Chen X; Giaccia AJ; Wu JC Circulation; 2008 Sep; 118(14 Suppl):S226-33. PubMed ID: 18824759 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger. Choi KO; Lee T; Lee N; Kim JH; Yang EG; Yoon JM; Kim JH; Lee TG; Park H Mol Pharmacol; 2005 Dec; 68(6):1803-9. PubMed ID: 16155211 [TBL] [Abstract][Full Text] [Related]